The Inhibition of Stat5 by a Peptide Aptamer Ligand Specific for the DNA Binding Domain Prevents Target Gene Transactivation and the Growth of Breast and Prostate Tumor Cells

Groner, 2012, The versatile regulation of cellular events by jak-stat signaling: From transcriptional control to microtubule dynamics and energy metabolism, Horm. Mol. Biol. Clin. Invest., 10, 193

Levy, 2002, Stats: Transcriptional control and biological impact, Nat. Rev. Mol. Cell Biol., 3, 651, 10.1038/nrm909

Mertens, 2007, Snapshot: Jak-stat signaling, Cell, 131, 612, 10.1016/j.cell.2007.10.033

Reich, 2006, Tracking stat nuclear traffic, Nat. Rev. Immunol., 6, 602, 10.1038/nri1885

Mohr, 2012, Dynamics and non-canonical aspects of jak/stat signalling, Eur. J. Cell Biol., 91, 524, 10.1016/j.ejcb.2011.09.005

Lee, 2012, Nongenomic stat5-dependent effects on golgi apparatus and endoplasmic reticulum structure and function, Am. J. Physiol. Cell Physiol., 302, C804, 10.1152/ajpcell.00379.2011

Wakao, 1994, Mammary gland factor (mgf) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response, EMBO J., 13, 2182, 10.1002/j.1460-2075.1994.tb06495.x

Liu, 1995, Cloning and expression of stat5 and an additional homologue (stat5b) involved in prolactin signal transduction in mouse mammary tissue, Proc. Natl. Acad. Sci. USA, 92, 8831, 10.1073/pnas.92.19.8831

Hennighausen, 2008, Interpretation of cytokine signaling through the transcription factors stat5a and stat5b, Genes Dev., 22, 711, 10.1101/gad.1643908

Kornfeld, 2008, The different functions of stat5 and chromatin alteration through stat5 proteins, Front. Biosci., 13, 6237, 10.2741/3151

Hanahan, 2011, Hallmarks of cancer: The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Yu, 2004, The stats of cancer—New molecular targets come of age, Nat. Rev. Cancer, 4, 97, 10.1038/nrc1275

Demaria, 2010, A stat3-mediated metabolic switch is involved in tumour transformation and stat3 addiction, Aging, 2, 823, 10.18632/aging.100232

Lewis, 2008, Stat5 as a diagnostic marker for leukemia, Exp. Rev. Mol. Diagn., 8, 73, 10.1586/14737159.8.1.73

Hoelbl, 2010, Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia, EMBO Mol. Med., 2, 98, 10.1002/emmm.201000062

Heuser, 2009, Modeling the functional heterogeneity of leukemia stem cells: Role of stat5 in leukemia stem cell self-renewal, Blood, 114, 3983, 10.1182/blood-2009-06-227603

Koptyra, 2011, Signal transducer and activator of transcription 5a/b: Biomarker and therapeutic target in prostate and breast cancer, Int. J. Biochem. Cell Biol., 43, 1417, 10.1016/j.biocel.2011.06.007

Verdine, 2007, The challenge of drugging undruggable targets in cancer: Lessons learned from targeting bcl-2 family members, Clin. Cancer Res., 13, 7264, 10.1158/1078-0432.CCR-07-2184

Borghouts, 2008, Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition, Mol. Cancer Res., 6, 267, 10.1158/1541-7786.MCR-07-0245

Walz, 2012, Essential role for stat5a/b in myeloproliferative neoplasms induced by bcr-abl1 and jak2(v617f) n mice, Blood, 119, 3550, 10.1182/blood-2011-12-397554

Tago, 2010, Stat5 activation is critical for the transformation mediated by myeloproliferative disorder-associated jak2 v617f mutant, J. Biol. Chem., 285, 5296, 10.1074/jbc.M109.040733

Choudhary, 2007, Activation mechanisms of stat5 by oncogenic flt3-itd, Blood, 110, 370, 10.1182/blood-2006-05-024018

Harir, 2008, Oncogenic kit controls neoplastic mast cell growth through a stat5/pi3-kinase signaling cascade, Blood, 112, 2463, 10.1182/blood-2007-09-115477

Liao, 2010, Transcription factor stat5a/b as a therapeutic target protein for prostate cancer, Int. J. Biochem. Cell Biol., 42, 186, 10.1016/j.biocel.2009.11.001

Clark, 2003, Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cdna microarrays, Oncogene, 22, 1247, 10.1038/sj.onc.1206247

Korch, 2003, Molecular characterization of human prostate carcinoma cell lines, Prostate, 57, 205, 10.1002/pros.10290

Dagvadorj, 2007, Autocrine prolactin promotes prostate cancer cell growth via janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway, Endocrinology, 148, 3089, 10.1210/en.2006-1761

Evans, 2007, Expression of socs1 and socs3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals, Oncogene, 26, 1941, 10.1038/sj.onc.1209993

Olayioye, 1999, Erbb receptor-induced activation of stat transcription factors is mediated by src tyrosine kinases, J. Biol. Chem., 274, 17209, 10.1074/jbc.274.24.17209

Tan, 2008, Transcription factor stat5 synergizes with androgen receptor in prostate cancer cells, Cancer Res., 68, 236, 10.1158/0008-5472.CAN-07-2972

Dagvadorj, 2008, Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo, Clinical Cancer Res., 14, 1317, 10.1158/1078-0432.CCR-07-2024

Thomas, 2011, Transcription factor stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo, Mol. Cancer Ther., 10, 347, 10.1158/1535-7163.MCT-10-0850

Hassel, 2008, Stat5 contributes to antiapoptosis in melanoma, Melanoma Res., 18, 378, 10.1097/CMR.0b013e32830ce7d7

Mirmohammadsadegh, 2006, Stat5 phosphorylation in malignant melanoma is important for survival and is mediated through src and jak1 kinases, J. Invest. Dermatol., 126, 2272, 10.1038/sj.jid.5700385

Walker, 2009, Reciprocal effects of stat5 and stat3 in breast cancer, Mol. Cancer Res., 7, 966, 10.1158/1541-7786.MCR-08-0238

Gutzman, 2007, Stat5 activation inhibits prolactin-induced ap-1 activity: Distinct prolactin-initiated signals in tumorigenesis dependent on cell context, Oncogene, 26, 6341, 10.1038/sj.onc.1210454

Sultan, 2005, Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells, Oncogene, 24, 746, 10.1038/sj.onc.1208203

Grimm, 2006, Fatality in mice due to oversaturation of cellular microrna/short hairpin rna pathways, Nature, 441, 537, 10.1038/nature04791

Yan, 2011, Unphosphorylated stat and heterochromatin protect genome stability, FASEB J., 25, 232, 10.1096/fj.10-169367

Li, 2008, Canonical and non-canonical jak-stat signaling, Trends Cell Biol., 18, 545, 10.1016/j.tcb.2008.08.008

Chueh, 2010, Mitochondrial translocation of signal transducer and activator of transcription 5 (stat5) in leukemic t cells and cytokine-stimulated cells, Biochem. Biophys. Res. Commun., 402, 778, 10.1016/j.bbrc.2010.10.112

Gilbert, 2012, Enterocyte stat5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation, EMBO Mol. Med., 4, 109, 10.1002/emmm.201100192

Bickle, 2006, Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures, Nat. protoc., 1, 1066, 10.1038/nprot.2006.32

Colas, 2008, The eleven-year switch of peptide aptamers, J. Biol., 7, 2, 10.1186/jbiol64

Hamdi, 2012, Yeast two-hybrid methods and their applications in drug discovery, Trends Pharmacol. Sci., 33, 109, 10.1016/j.tips.2011.10.008

Borghouts, 2008, Peptide aptamer libraries, Comb. Chem. High Throughput Screen., 11, 135, 10.2174/138620708783744462

Becker, 1998, Three-dimensional structure of the stat3beta homodimer bound to DNA, Nature, 394, 145, 10.1038/28101

Borghouts, 2012, A membrane penetrating aptamer inhibits stat3 function and suppresses the growth of stat3 addicted tumor cells, JAK-STAT, 1, 44, 10.4161/jkst.18947

Melen, 2003, Importin alpha nuclear localization signal binding sites for stat1, stat2, and influenza a virus nucleoprotein, J. Biol. Chem., 278, 28193, 10.1074/jbc.M303571200

Groner, 2002, Transcription factor regulation in mammary epithelial cells, Domest. Anim. Endocrinol., 23, 25, 10.1016/S0739-7240(02)00142-X

Engblom, 2007, Direct glucocorticoid receptor-stat5 interaction in hepatocytes controls body size and maturation-related gene expression, Genes Dev., 21, 1157, 10.1101/gad.426007

Demaison, 2002, High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter, Human Gene Ther., 13, 803, 10.1089/10430340252898984

Butz, 2000, Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral e6 oncoprotein, Proc. Natl. Acad. Sci. USA, 97, 6693, 10.1073/pnas.110538897

Baines, 2006, Peptide aptamers as guides for small-molecule drug discovery, Drug Discov. Today, 11, 334, 10.1016/j.drudis.2006.02.007

Wathes, 2013, Progressive multifocal leukoencephalopathy associated with ruxolitinib, N. Engl. J. Med., 369, 197, 10.1056/NEJMc1302135

Groner, 2012, Increasing the range of drug targets: Interacting peptides provide leads for the development of oncoprotein inhibitors, Bioengineered, 3, 320, 10.4161/bioe.21272

Bardou, 2009, Peptide aptamers for small molecule drug discovery, Methods Mol. Biol., 535, 373, 10.1007/978-1-59745-557-2_21